Katagiri A
No ORCID on file
· 6 papers in corpus
· active 2012-2015
Study types
- article 2
- other 1
Condition tags
- dysmenorrhea 2
- adenomyosis 2
- endometriosis 1
Top journals
Frequent coauthors
- Ishikawa M 6
- Nakayama K 6
- Ishibashi T 6
- Kobayashi H 6
- Iida K 5
- Miyazaki K 5
- Rahman MT 4
- Nakayama N 4
- Rahman M 4
- Kentaro Nakayama 3
article
2015
AIM: Conventional microwave endometrial ablation (MEA) can be insufficient to control menorrhagia resulting from adenomyosis. We compared the standard single ablation technique with multiple MEA - repeating ablation three times in the same …
2013
Ovarian cancer treatment presently does not reflect molecular differences in histologic subtype. Ovarian clear cell carcinoma (OCCC) exhibits several differences in terms of molecular pathogenesis and tumor behavior from the more common, ch…
2013
In this study, we examined the clinical significance of KRAS and MAPK1 amplification and assessed whether these amplified genes were potential therapeutic targets in type II ovarian carcinoma. Using fluorescence in situ hybridization, immun…
article
2013
AIM: We aimed to evaluate the efficacy of microwave endometrial ablation at a frequency of 2.45 GHz in women with menorrhagia. This method has been attracting attention as an alternative to hysterectomy in the treatment of functional and or…
2012
BackgroundThis study examined the clinical significance of NAC1 and the expression level of its potential downstream target fatty acid synthase (FASN) in ovarian clear cell carcinomas (OCCCs), and evaluated the NAC1/FASN pathway as a potent…
other
2012
Recently, the ARID1A gene has been identified as a novel tumor suppressor in ovarian clear cell carcinoma. The prognostic significance of the loss of ARID1A expression is not known. The current study was designed to evaluate whether ARID1A …